1.
Lam I, Ndayisaba A, Lewis AJ, et al. Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions. Neuron. 2024. doi:10.1016/j.neuron.2024.06.002.
1.
Bellomo TR, Liu Y, Gilliland TC, et al. Associations between lipoprotein(a), oxidized phospholipids, and extra-coronary vascular disease. Journal of lipid research. 2024:100585. doi:10.1016/j.jlr.2024.100585.
1.
Agarwala A, Satish P, Rifai MA, et al. Identification and Management of Atherosclerotic Cardiovascular Disease Risk in South Asian Populations in the U.S. JACC. Advances. 2023;2(2). doi:10.1016/j.jacadv.2023.100258.
1.
Schaefer EAK, Meixiong J, Mark C, et al. Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C. World journal of gastroenterology. 2016;22(45):9954-9965. doi:10.3748/wjg.v22.i45.9954.